Showing results (11-20 of 134) with videos related to
Sort By:
Pageof 14
Frontiers in Chemistry|July 14, 2020
Recent Advances in Rare-Earth-Doped Nanoparticles for NIR-II Imaging and Cancer TheranosticsZhenfeng Yu, Christina Eich, Luis J CruzChemmedchem|May 22, 2007
Synthesis and structure-activity relationship of cytotoxic marine cyclodepsipeptide IB-01212 analoguesLuis J Cruz, Andres Francesch, Carmen Cuevas, et al.Molecular Immunology|October 19, 2004
Broader cross-reactivity after conjugation of V3 based multiple antigen peptides to HBsAgEnrique Iglesias, Julio C Aguilar, Luis J Cruz, et al.Biomaterials|July 5, 2011
The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cellsLuis J Cruz, Paul J Tacken, Remco Fokkink, et al.Current Pharmaceutical Biotechnology|July 29, 2020
Enhanced Intracellular Delivery of Curcumin by Chitosan-Lipoic Acid as Reduction-Responsive NanoparticlesSomayeh Rezaei, Soheila Kashanian, Yadollah Bahrami, et al.Frontiers in Genome Editing|November 21, 2022
Nanoparticles targeting hematopoietic stem and progenitor cells: Multimodal carriers for the treatment of hematological diseasesLuis J Cruz, Somayeh Rezaei, Frank Grosveld, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|September 7, 2021
19F-nanoparticles: Platform for in vivo delivery of fluorinated biomaterials for 19F-MRIAlvja Mali, Eric L Kaijzel, Hildo J Lamb, et al.Molecules (Basel, Switzerland)|March 11, 2020
Redox-Sensitive and Hyaluronic Acid-Functionalized Nanoparticles for Improving Breast Cancer Treatment by Cytoplasmic 17α-Methyltestosterone DeliverySomayeh Rezaei, Soheila Kashanian, Yadollah Bahrami, et al.Molecular Pharmaceutics|August 19, 2010
The antitumoral depsipeptide IB-01212 kills Leishmania through an apoptosis-like process involving intracellular targetsJuan R Luque-Ortega, Luis J Cruz, Fernando Albericio, et al.Molecular Pharmaceutics|March 26, 2009
Kahalalide F, an antitumor depsipeptide in clinical trials, and its analogues as effective antileishmanial agentsLuis J Cruz, Juan R Luque-Ortega, Luis Rivas, et al.Pageof 14